Skip to content

    Allogene Therapeutics (ALLO) stock price & financials

    View ALLO earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+74.1% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $0
    $0
    $0
    $0
    $0
    $0
    $4.64M
    Operating Profit
    -$71.77M
    -$60.49M
    -$65.19M
    -$56.82M
    -$44.90M
    +37.4%
    -$42.40M
    +29.9%
    -$46.09M
    +29.3%
    -$46.92M
    +17.4%
    Strengthening
    Net Profit
    -$66.29M
    -$59.94M
    -$59.73M
    -$50.94M
    -$41.40M
    +37.5%
    -$38.81M
    +35.3%
    -$42.61M
    +28.7%
    -$42.68M
    +16.2%
    Strengthening
    EPS
    $-0.32
    $-0.28
    $-0.23
    $-0.19
    +40.6%
    $-0.18
    +35.7%
    $-0.13
    +43.5%
    Strengthening
    Other Income
    $5.48M
    $994.0K
    $5.46M
    $5.88M
    $3.50M
    -36.1%
    $3.59M
    +261.6%
    $3.48M
    -36.1%
    $4.24M
    -27.8%
    Strengthening
    Interest
    $100.0K
    $81.0K
    $150.0K
    $268.0K
    $344.0K
    +244.0%
    $313.0K
    +286.4%
    $300.0K
    +100.0%
    $343.0K
    +28.0%
    Strengthening
    Depreciation
    Profit before Tax
    MarginsOPM
    -1011.2%
    Tax
    ReturnsROIC
    3.2%
    2.9%
    2.9%
    2.4%
    2.0%
    -37.5%
    1.9%
    -35.3%
    2.0%
    -28.7%
    2.0%
    -16.2%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$92.43M$175.13M$183.35M$173.31M$61.90M$83.16M$75.22M$51.69M$38.63M
    Short-Term Investments
    Total Current Assets$467.98M$544.58M$845.13M$471.32M$528.82M$459.12M$303.39M$257.75M$340.00M
    Net PP&E$41.61M$100.94M$160.13M$181.02M$196.43M$163.18M$131.26M$112.73M$105.12M
    Goodwill
    Intangibles$754.0K$151.0K$0
    Total Assets$773.86M$717.80M$1.23B$1.05B$821.58M$642.84M$548.71M$415.90M$550.09M
    LiabilitiesTotal Current Liabilities$29.46M$33.08M$94.32M$47.91M$53.73M$37.08M$35.52M$32.51M$31.73M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$34.46M$51.35M$50.81M$69.93M$95.12M$88.35M$83.25M$75.05M$70.35M
    Total Liabilities$70.69M$88.78M$148.21M$125.63M$154.70M$130.60M$126.53M$123.36M$113.92M
    EquityCommon Stock & APIC$121.0K$124.0K$140.0K$142.0K$144.0K$169.0K$212.0K$229.0K$345.0K
    Retained Earnings-$211.53M-$396.12M-$712.50M-$894.55M-$1.23B-$1.56B-$1.82B-$2.01B-$2.10B
    Total Equity$703.16M$629.02M$1.01B$925.20M$666.88M$512.23M$422.18M$292.54M$436.18M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$44.65M-$137.35M-$115.09M-$184.81M-$220.52M-$237.73M-$200.30M-$149.25M-$102.20M
    Cash from Investing-$632.80M$164.08M-$505.12M$163.66M$106.16M$163.29M$75.69M$95.56M-$131.60M
    Cash from Financing$771.18M$58.96M$633.59M$11.96M$2.95M$95.69M$116.67M$30.16M$220.09M
    SummaryCapital Expenditure-$3.23M-$50.79M-$65.96M-$21.45M-$5.19M-$1.52M-$694.0K-$386.0K-$402.0K
    Free Cash Flow-$47.89M-$188.14M-$181.05M-$206.26M-$225.71M-$239.25M-$200.99M-$149.63M-$102.60M
    FCF Margin-180.8%-144685.9%-251841.1%-913609.1%

    Ratios